Advertise on podcast: ASCPT Podcast Channel

In this episode of clinpharmpod, Dr. Avery McIntosh shares his thoughts on CPT’s new call for papers for a themed issue on quantitative clinical pharmacology for evidence generation and next-generation drug development. He and host Alaina Webster discuss the need for better cross-discipline alignment among statistics, clinical pharmacology, pharmacometrics, QSP, and regulatory science; areas of interest including model-informed drug development, innovative trial designs, real-world evidence and causal inference, AI/ML and hybrid models, federated learning, advanced therapeutics, and plausible mechanism pathways and new approach methodologies (NAMs). Submissions are due October 31, 2026. You can find more information about this call for papers here.

Join Dr. Janet Woodcock and Dr. Marshall Summer as they discuss their two review papers in Clinical and Translational Science on rare disease trial design: “Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model is Crucial” and “The Placebo Effect in Rare Disease Clinical Trials: Measurement Impact and Statistical Approaches for Patient as Own Control Designs.” They delve into why traditional randomized controlled trials can be infeasible for small, heterogeneous rare disease populations, how patient-as-own-control and other alternative statistical designs can add rigor while reducing false negatives, as well as practical ways to address placebo effects, bias, and endpoint selection, emphasizing natural history studies and patient-centered input. You can find more information about The Haystack Project mentioned in this episode here: https://haystackproject.org/.

Join Clinical and Translational Science editors Erica Woodahl and Liewei Wang and Editor-in-Training Mai-Uyen Nguyen to hear about CTS’s call for papers for a special collection on how translational science can advance precision medicine, marking the 10th anniversary of CTS joining the ASCPT Journal Family. The editors highlight desired submission areas including translational approaches, new tools and technologies from preclinical models to clinical implementation, trial design and real-world evidence, regulatory/ethical/policy considerations for genomic data and testing costs, and pharmacoequity. Submissions are due October 1, 2026.

Working on research focusing on an understudied population? Consider submitting to the CPT themed issue “Advancing Therapeutics for Understudied Patient Groups.” This episode dives into the call for papers and what aspects of this topic editors are really hoping to see highlighted in submitted research. Submission deadline: June 30, 2026.

Check out the latest Clinical Pharmacology & Therapeutics call for papers on “Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption.” The submission deadline is June 1, 2026, so submit your research soon!

Listen in as former Clinical Pharmacology & Therapeutics Editor-in-Chief Piet van der Graaf and former Deputy Editor-in-Chief Kathy Giacomini discuss their journeys to clinical pharmacology, ASCPT, and the CPT editorship. They reminisce about mentors and influential people in their lives, challenges and milestones faced at CPT, and how scientific publishing continues to evolve and change.

CPT: Pharmacometrics & Systems Pharmacology’s (PSP) 2025 themed issue focused on Pediatric Rare Diseases, which impact more than 25 million people worldwide. Listen as PSP Associate Editors Ping Zhao and Rajat Desikan and Guest Editor Jane Knöchel discuss the conception and planning of this exciting issue as well as articles and topics they found especially interesting and insightful. Interested in publishing with ASCPT? You can find our open Calls for Papers here.

Clinical and Translational Science (CTS) has issued a Call for Papers for a special collection on “Quantitative Medicine for Drug Discovery, Development, and Clinical Utilization.” Listen as CTS Associate Editor Lei Zhang and guest editors Chunze Li and Lanfranco Pellesi discuss the need for quantitative research in clinical pharmacology and translational medicine, what types of papers they’d like to see submitted to the special collection, and how having your paper included in a special collection can boost engagement with your research. Submissions for this collection should be received no later than January 31, 2026.

Incoming Clinical Pharmacology & Therapeutics Editor-in-Chief Karen Rowland Yeo is launching a Call for Papers for the May 2026 issue of CPT, which will be titled “ Elevating the Global Impact of Clinical Pharmacology”. Hear Karen discuss how her childhood and university experiences in South Africa shaped and continue to influence her approach to clinical pharmacology and translational science, her vision for CPT, and focusing on pharmacoequity in her first themed issue.

Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational Science Associate Editor Sonal Singh and Guest Editor Zachary Taylor discuss the open Biomarkers Call for Papers and what themes they’d like to see covered in this upcoming special collection, as well as the deadline for submission.

Clinical Pharmacology & Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT’s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field developing in the future. Listen to their conversation, and then check out this important issue!

Clinical and Translational Science Associate Editor Mohamed Shahin sits down to discuss CTS’s latest special collection on artificial intelligence and machine learning. He delves into the decision-making process in choosing this theme, trends in AI/ML research that can be seen in the collection, and where he sees this field of research going next. If you’re interested in seeing what other calls for papers CTS has open, click here.

Wiley’s Sarah Whalen stops by to discuss the publisher’s Transformational Agreements for Open Access publishing. She shares how to find out if your Open Access fees might be covered under an existing transformational agreement, the benefits of Open Access publishing, how to navigate licensing agreements, and more. Sarah specifically mentions Wiley Author Services and the Transformational Agreement Eligibility Checker, so be sure to check out those resources after you’ve listened to this episode.

Clinical and Translational Science Editor-in-Chief John Wagner and Associate Editor Elvin Price stop by the podcast to discuss CTS‘s latest special collection on Diversity, Equity, and Inclusion. They share their thoughts on the importance of DEI in clinical pharmacology and translational science as well as trends found in the collection and where they see research headed in the future. They also discuss other opportunities to submit your research to CTS, and you can read about all these open calls for papers here.

Led by CPT: Pharmacometrics & Systems Pharmacology Associate Editor Dr. Jonathan French, PSP has launched a call for papers for “Applications and Innovations in Model-Based Meta-Analysis (MBMA).” Join host Alaina Webster, as she sits down with Dr. French, PSP Editor-in-Training Dr. Jiawei Zhou, and guest editors Drs. Phyllis Chan, Monica Simeoni, and Matt Zierhut to discuss the thought processes around this theme, manuscript types, and potential areas of interest. All submissions are due by June 15, 2025. If you have questions about the theme or submission process, please contact ASCPT Managing Editor Alethea Gerding at [email protected].